Literature DB >> 9768646

A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets.

M J Econs1, N E Friedman, P S Rowe, M C Speer, F Francis, T M Strom, C Oudet, J A Smith, J T Ninomiya, B E Lee, H Bergen.   

Abstract

Previous investigators described a kindred with an X-linked dominant form of phosphate wasting in which affected children did not have radiographic evidence of rickets, whereas older individuals were progressively disabled by severe bowing. They proposed that this kindred suffered from a distinct disorder that they referred to as adult-onset vitamin D-resistant hypophosphatemic osteomalacia (AVDRR). We recently identified a gene, PHEX, that is responsible for the disorder X-linked hypophosphatemic rickets. To determine whether AVDRR is a distinct form of phosphate wasting, we searched for PHEX mutations in affected members of the original AVDRR kindred. We found that affected individuals have a missense mutation in PHEX exon 16 that results in an amino acid change from leucine to proline in residue 555. Clinical evaluation of individuals from this family indicates that some of these individuals display classic features of X-linked hypophosphatemic rickets, and we were unable to verify progressive bowing in adults. In light of the variability in the clinical spectrum of X-linked hypophosphatemic rickets and the presence of a PHEX mutation in affected members of this kindred, we conclude that there is only one form of X-linked dominant phosphate wasting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768646     DOI: 10.1210/jcem.83.10.5167

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  A report of familial hyperphosphataemia in an Irish family.

Authors:  S W Li Voon Chong; S Ah Kion; M J Cullen
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

Review 2.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

Authors:  Young H Lim; Diana Ovejero; Jeffrey S Sugarman; Cynthia M C Deklotz; Ann Maruri; Lawrence F Eichenfield; Patrick K Kelley; Harald Jüppner; Michael Gottschalk; Cynthia J Tifft; Rachel I Gafni; Alison M Boyce; Edward W Cowen; Nisan Bhattacharyya; Lori C Guthrie; William A Gahl; Gretchen Golas; Erin C Loring; John D Overton; Shrikant M Mane; Richard P Lifton; Moise L Levy; Michael T Collins; Keith A Choate
Journal:  Hum Mol Genet       Date:  2013-09-04       Impact factor: 6.150

5.  Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type.

Authors:  Marcos Morey; Lidia Castro-Feijóo; Jesús Barreiro; Paloma Cabanas; Manuel Pombo; Marta Gil; Ignacio Bernabeu; José M Díaz-Grande; Lourdes Rey-Cordo; Gema Ariceta; Itxaso Rica; José Nieto; Ramón Vilalta; Loreto Martorell; Jaime Vila-Cots; Fernando Aleixandre; Ana Fontalba; Leandro Soriano-Guillén; José M García-Sagredo; Sixto García-Miñaur; Berta Rodríguez; Saioa Juaristi; Carmen García-Pardos; Antonio Martínez-Peinado; José M Millán; Ana Medeira; Oana Moldovan; Angeles Fernandez; Lourdes Loidi
Journal:  BMC Med Genet       Date:  2011-09-08       Impact factor: 2.103

6.  PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

Authors:  Céline Gaucher; Odile Walrant-Debray; Thy-Minh Nguyen; Laure Esterle; Michèle Garabédian; Frédéric Jehan
Journal:  Hum Genet       Date:  2009-02-15       Impact factor: 4.132

Review 7.  Endocrine crosstalk between muscle and bone.

Authors:  Marco Brotto; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

8.  MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.

Authors:  Benjamin Salmon; Claire Bardet; Mayssam Khaddam; Jiar Naji; Benjamin R Coyac; Brigitte Baroukh; Franck Letourneur; Julie Lesieur; Franck Decup; Dominique Le Denmat; Antonino Nicoletti; Anne Poliard; Peter S Rowe; Eric Huet; Sibylle Opsahl Vital; Agnès Linglart; Marc D McKee; Catherine Chaussain
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications.

Authors:  Silje Rafaelsen; Stefan Johansson; Helge Ræder; Robert Bjerknes
Journal:  Eur J Endocrinol       Date:  2015-11-05       Impact factor: 6.664

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.